CroFab Dosing for North American Crotalid Envenomation
The recommended initial dose of CroFab is 4 to 6 vials administered intravenously, with the starting dose ranging from a minimum of 4 vials to a maximum of 12 vials based on envenomation severity, followed by repeat doses of 4 to 6 vials until initial control is achieved, then maintenance dosing of 2 vials every 6 hours for up to 18 hours (3 doses). 1
Initial Dosing Phase
Start with 4 to 6 vials IV as the standard initial dose, though clinical judgment may dictate using up to 12 vials for severe envenomations 1. The FDA label explicitly states this dosing should be administered as soon as possible when any signs of envenomation are present—local injury, coagulation abnormalities, or systemic symptoms 1.
After completing the first dose, observe the patient for up to 1 hour to assess whether initial control has been achieved 1. Initial control means:
- Local injury progression has stopped (leading edge not advancing)
- Systemic symptoms have resolved
- Coagulation parameters have normalized or are trending toward normal 1
Repeat Dosing Until Control
If initial control is NOT achieved after the first dose, administer additional 4 to 6 vial doses repeatedly until control is established 1. There is no predetermined maximum number of vials—dosing continues until the envenomation is controlled. Research data shows patients may require anywhere from 4 to 18 vials to achieve initial control 2.
Maintenance Dosing
Once initial control is achieved, give 2 vials every 6 hours for up to 18 hours (total of 3 maintenance doses) 1. This maintenance phase is critical, as recurrent or delayed-onset venom effects (particularly coagulopathy) commonly occur in patients who do not receive recommended maintenance dosing 2.
Administration Details
Reconstitute each vial with 18 mL of 0.9% sodium chloride, mixing by continuous gentle inversion (1-2 inversions per second) until no solid material remains visible 1. Do not shake, as this causes foaming.
Dilute all reconstituted vials to a total volume of 250 mL with 0.9% sodium chloride and infuse IV over 60 minutes 1. However, start the infusion slowly:
- First 10 minutes: 25-50 mL/hour while monitoring for allergic reactions
- If no reaction: increase to full 250 mL/hour rate until completion 1
Use the reconstituted product within 4 hours 1.
Important Clinical Considerations
CroFab is preferred over the older Wyeth polyvalent antivenom due to improved safety profile and the fact that Wyeth production has been discontinued 3. Expert consensus guidelines from 2009 designated CroFab as the preferred agent for crotaline envenomation 3.
Hospitals in endemic areas should stock sufficient antivenom for multiple simultaneous victims 3. The expert consensus recommends stocking 12 vials for 8-hour treatment or 18 vials for 24-hour treatment of a single 100-kg patient, but facilities should perform hazard vulnerability assessments based on local snake populations 3.
Infusion reactions (fever, low back pain, wheezing, nausea) may occur and are typically rate-related—slow the infusion rate if these develop 1. Severe anaphylactic reactions are rare, occurring in approximately 0.5% of patients 4.
Common Pitfalls to Avoid
- Underdosing maintenance therapy: Recurrent coagulopathy is common when maintenance doses are omitted 2
- Delaying treatment: CroFab was shown effective when given within 6 hours of snakebite; administer as soon as envenomation signs appear 1
- Stopping too early: Continue repeat dosing until initial control is achieved, regardless of number of vials used 1
- Inadequate monitoring: Observe for at least 1 hour after each dose to assess response 1
Recent data shows the median total CroFab usage is approximately 10 vials per patient, with fewer administration events compared to alternative antivenoms 5. Optimal dosing beyond the 18-hour maintenance period has not been determined, but additional 2-vial doses may be given as clinically necessary 1.